US20160120625A1 - Abutment - Google Patents
Abutment Download PDFInfo
- Publication number
- US20160120625A1 US20160120625A1 US14/896,569 US201414896569A US2016120625A1 US 20160120625 A1 US20160120625 A1 US 20160120625A1 US 201414896569 A US201414896569 A US 201414896569A US 2016120625 A1 US2016120625 A1 US 2016120625A1
- Authority
- US
- United States
- Prior art keywords
- abutment
- nanostructures
- basic body
- dental implant
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C8/00—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools
- A61C8/0012—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools characterised by the material or composition, e.g. ceramics, surface layer, metal alloy
- A61C8/0013—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools characterised by the material or composition, e.g. ceramics, surface layer, metal alloy with a surface layer, coating
- A61C8/0015—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools characterised by the material or composition, e.g. ceramics, surface layer, metal alloy with a surface layer, coating being a conversion layer, e.g. oxide layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C8/00—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools
- A61C8/0048—Connecting the upper structure to the implant, e.g. bridging bars
- A61C8/005—Connecting devices for joining an upper structure with an implant member, e.g. spacers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- C—CHEMISTRY; METALLURGY
- C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
- C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
- C23C22/00—Chemical surface treatment of metallic material by reaction of the surface with a reactive liquid, leaving reaction products of surface material in the coating, e.g. conversion coatings, passivation of metals
- C23C22/05—Chemical surface treatment of metallic material by reaction of the surface with a reactive liquid, leaving reaction products of surface material in the coating, e.g. conversion coatings, passivation of metals using aqueous solutions
- C23C22/06—Chemical surface treatment of metallic material by reaction of the surface with a reactive liquid, leaving reaction products of surface material in the coating, e.g. conversion coatings, passivation of metals using aqueous solutions using aqueous acidic solutions with pH less than 6
-
- C—CHEMISTRY; METALLURGY
- C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
- C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
- C23C22/00—Chemical surface treatment of metallic material by reaction of the surface with a reactive liquid, leaving reaction products of surface material in the coating, e.g. conversion coatings, passivation of metals
- C23C22/73—Chemical surface treatment of metallic material by reaction of the surface with a reactive liquid, leaving reaction products of surface material in the coating, e.g. conversion coatings, passivation of metals characterised by the process
- C23C22/77—Controlling or regulating of the coating process
-
- C—CHEMISTRY; METALLURGY
- C23—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
- C23C—COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
- C23C22/00—Chemical surface treatment of metallic material by reaction of the surface with a reactive liquid, leaving reaction products of surface material in the coating, e.g. conversion coatings, passivation of metals
- C23C22/78—Pretreatment of the material to be coated
-
- C—CHEMISTRY; METALLURGY
- C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
- C25D—PROCESSES FOR THE ELECTROLYTIC OR ELECTROPHORETIC PRODUCTION OF COATINGS; ELECTROFORMING; APPARATUS THEREFOR
- C25D3/00—Electroplating: Baths therefor
- C25D3/02—Electroplating: Baths therefor from solutions
- C25D3/54—Electroplating: Baths therefor from solutions of metals not provided for in groups C25D3/04 - C25D3/50
-
- C—CHEMISTRY; METALLURGY
- C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
- C25D—PROCESSES FOR THE ELECTROLYTIC OR ELECTROPHORETIC PRODUCTION OF COATINGS; ELECTROFORMING; APPARATUS THEREFOR
- C25D5/00—Electroplating characterised by the process; Pretreatment or after-treatment of workpieces
- C25D5/34—Pretreatment of metallic surfaces to be electroplated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/12—Materials or treatment for tissue regeneration for dental implants or prostheses
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
Definitions
- the present invention relates to an abutment of a dental implant system for connecting a dental implant and a suprastructure as well as to a process for providing sites of improved protein adherence on an abutment basic body.
- Dental implants are well known in the art. Generally, they comprise an anchoring part intended to be anchored in a patient's jaw bone and a head part intended to form the basis on which a suprastructure, such as a bridge or crown, is mounted. The mounting of the suprastructure is thereby often performed by using an intermediate, i.e. a so-called “abutment” (also referred to as “secondary part”), as it is the case in a “two-part implant system” or “multi-part implant system”.
- abutment also referred to as “secondary part”
- the implant Apart from being biocompatible and having sufficient mechanical strength, it is required that the implant provides good osteointegration.
- osteointegration designates the direct structural and functional connection between living bone and the surface of the implant.
- a good osteointegration means that the implant, after reaching a primary stability by screwing it into the bone, safely ossifies within a short healing time so that a permanent bond between implant and bone is obtained.
- the soft tissue plays a fundamental role in establishing an effective seal between the oral environment and the endosseous part of a dental implant and, thus, also a barrier for bacteria to adhere on the soft tissue contact surface and the bone tissue contact surface of the implant system.
- the presence of bacteria on the implant system's surface may lead to an inflammation of the peri-implant mucosa, and, if left untreated, the inflammation spreads apically and results in bone resorption.
- the soft tissue contact surface of the implant system would ideally not only provide a surface showing a low tendency for bacteria to adhere, but also allow a relatively strong and fast interaction between the soft tissue and the implant to be established (also referred to as “soft tissue integration”), in order to quickly provide an effective seal between the oral environment and the endosseous part.
- EP-A-2161000 suggests an abutment comprising a soft tissue contact surface that is at least partially hydroxylated.
- improved soft tissue integration is explained by the loose connective tissue to become organized and replaced be newly formed collagen fibers.
- the object of the present invention is thus to provide an abutment the outer surface of which establishes a good soft tissue integration, i.e. a relatively strong interaction between abutment and soft tissue in a relatively timely manner, and which at the same time shows a low tendency for bacteria to adhere.
- the present invention relates to a abutment comprising an abutment basic body extending from an apical end to a coronal end arranged opposite to the apical end, the abutment comprising a dental implant connecting portion facing the apical end and adapted to fit with a corresponding abutment connecting portion of the dental implant and/or an intermediate part to be directly or indirectly connected with the dental implant.
- the abutment further comprises a support portion facing the coronal end designed such to allow the suprastructure to be mounted directly or indirectly, i.e. using at least one intermediate, as it is the case in multi-part dental implant systems.
- the abutment comprises nanostructures formed on the outer surface of the abutment basic body, said nanostructures extending in at least two dimensions to 200 nm at most.
- the nanostructures are formed on the outer surface of a soft tissue contact region of the abutment basic body, said region being arranged between the dental implant connecting portion and the support portion of the abutment basic body.
- the outer surface of the soft tissue contact region is in the following also referred to as “soft tissue contact surface”.
- the nanostructures form retention sites, allowing for an improved initial adherence of proteins of the cells of the surrounding soft tissue.
- transmembrane proteins specifically integrins
- integrins can directly or indirectly, i.e. by mediation of other proteins, adhere to the nanostructures and, thus, establish an anchorage of the cells to the abutment's soft tissue contact surface.
- laminins which is linked with the extracellular domain of the integrins, can also play an important role, as well as plasma proteins, such as albumin, fibrinogen and fibronectin.
- the nanostructures forming retention sites allow for an optimal soft tissue interaction of the abutment and, consequently, an effective seal between the dental implant system's endosseous part and the oral environment to be achieved.
- the outer surface of the abutment basic body on which the nanostructures are formed is smooth, e.g. machined or polished.
- the surface topography is smooth when regarded in macroscopic and microscopic scale, but nevertheless provides a nanoscopic structure due to the presence of the nanostructures.
- These nanostructures are small enough not to interfere with the low plaque forming tendency of the soft tissue contact surface, but big enough to allow proteins of the surrounding soft tissue cells to adhere.
- the soft tissue contact surface's tendency for adherence of bacteria is low, while at the same time protein adherence of the surrounding soft tissue cells can take place.
- the outer surface of the abutment basic body being smooth, it can also be minimally rough, i.e. having a roughness as e.g. obtainable by acid etching.
- the term “dental implant” as used in the context of the present invention relates to the primary part of a dental implant system, i.e. the part that is actually implanted in the bone, whereas the term “abutment” relates to the “secondary part” of the dental implant system.
- the term “suprastructure” relates to the prosthetic element of the dental restoration, and in particular relates to a crown or bridge.
- the outer surface of the abutment basic body on which the nanostructures are formed is preferably smooth
- the bone tissue contact surface of the dental implant typically comprises a macroscopic topography, achieved e.g. by sand-blasting and/or machining, as well as a microscopic topography, achieved e.g. by acid etching.
- the present invention encompasses abutments in which nanostructures are formed on the soft tissue contact surface only, as well as embodiments in which they are formed on the surface of additional regions than the soft tissue contact region, and embodiments in which they are formed on the whole surface of the abutment basic body.
- the nanostructures are at least predominantly in crystalline phase. More preferably, the nanostructures are in an at least approximately purely crystalline phase.
- the nanostructures can have different shapes including a needle-like shape, a leaf-like shape, a flower-like shape, a sphere-like shape or a nodule-like shape.
- the term “needle-like shape” encompasses any shape having a length to diameter ratio of more than 1:1. Thereby, the diameter is to be understood as the expansion of the nanostructure in a direction perpendicular to the longitudinal direction.
- the nanostructures have an average length-to-diameter ratio of more than 1 to 1, more preferably of at least 1.5 to 1, most particularly ranging from 1.5 to 1 to 4 to 1.
- the nanostructures according to the present invention preferably extend in at least two dimensions to 200 nm at most. More specifically, the nanostructures preferably have an average diameter of about 10 nm to 150 nm and an average length of about 5 nm to 500 nm.
- a relatively high hydrophilicity of the abutment's surface can be achieved, which can further contribute to a good soft tissue interaction.
- at least a part of the surface of the abutment thus, has a hydrophilicity defined by a contact angle of less than 90°, more preferably less than 30°, most preferably less than 10°, when contacted with water.
- the abutment basic body is made of titanium or a titanium alloy.
- a respective basic body allows nanostructures to be formed on its surface in a relatively simple and reproducible manner, as will be shown below.
- any suitable grade of titanium or titanium alloy known to the skilled person can be used, including titanium of grade 2 to grade 4.
- titanium alloy this is preferably a titanium zirconium (TiZr) alloy, typically comprising Zr in an amount of 13 to 17%.
- TiZr titanium zirconium
- a titanium aluminium vanadium alloy specifically Ti-6Al-4V (TAV)
- a titanium aluminium niobium alloy specifically Ti-6Al-7Nb (TAN)
- TAV titanium aluminium niobium alloy
- Ti-6Al-7Nb Ti-6Al-7Nb
- the nanostructures comprise titanium hydride and/or titanium oxide.
- nanostructures comprise titanium hydride, they typically comprise TiH 2 , whereas in case the nanostructures comprise titanium oxide, they typically comprise TiO 2 .
- the present invention also relates to a process for providing sites of improved protein adherence on an abutment basic body, as described above.
- the nanostructures are grown on the outer surface of the abutment basic body by treating the outer surface of the abutment basic body with an aqueous solution.
- the nanostructures are grown means that they are not formed by a mechanical removing process or by subjecting the surface of the body to other mechanical structuring processes. Rather, the formation of the nanostructures occurs gradually in that they “build up” over time by treating the outer surface of the abutment basic body with the aqueous solution.
- aqueous solution as used in the context of the present invention encompasses both pure water as well as a solution in which the solvent is water.
- the aqueous solution is an acidic solution comprising at least one component selected from the group consisting of hydrogen fluoride, nitric acid, hydrochloric acid, sulphuric acid, tartaric acid, oxalic acid, citric acid and acetic acid, and/or mixtures thereof.
- the abutment basic body is typically made of titanium or a titanium alloy.
- the growing of the nanostructures is performed by cathodic polarization (also referred to as “cathodic hydridation”), in which the abutment basic body forms the cathode.
- cathodic polarization also referred to as “cathodic hydridation”
- the abutment basic body forms the cathode.
- At least a portion of the outer surface of the abutment basic body is pickled with a pickling solution in order to at least partially remove a titanium oxide layer present on the outer surface.
- a pickling solution comprising at least one component selected from the group consisting of nitric acid, hydrofluoric acid, ammonium fluoride, hydrochloric acid and sulphuric acid, and/or mixtures thereof, particularly a mixture of nitric acid and hydrofluoric acid, is thereby preferably used.
- this is preferably performed in a buffer having a pH in the range from 0 to 6.
- the temperature is preferably set in a range from 5 to 95° C., preferably from 10 to 75° C., more preferably from 15 to 50° C., most preferably at about room temperature.
- the nanostructures can be grown on the outer surface of the abutment basic body by storing the outer surface of the abutment basic body in the aqueous solution.
- the storing is typically carried out by using a 0.9% NaCl solution, more specifically having a pH of 2 to 7, preferably 3 to 6.
- a 0.9% NaCl solution more specifically having a pH of 2 to 7, preferably 3 to 6.
- any other suitable aqueous solution can be used including pure water.
- the storing is carried out for at least one month, more preferably at least two months, most preferably at least four months.
- the storage time depends on the surface topography of the outer surface of the abutment basic body. For a machined surface, the storage times required for the growing of the nanostructures has been found to be longer than for a rough surface. However, also for a machined surface, nanostructures are detected after two months of storing.
- this is performed at an elevated temperature, i.e. a temperature above room temperature, since nanostructure formation has been shown to be particularly pronounced at these temperatures.
- a temperature in a range of about 50° C. to 250° C., more particularly about 100° C. to 180° C., and most preferably about 120° C. to 150° C. has been shown to be particularly preferred, since the storing time required for the growing of nanostructures can be shortened substantially. A storing over months is, thus, not required when performing a (hydro-)thermal treatment at the temperatures specified above.
- the process of the present invention encompasses embodiments in which only the soft tissue contact region is subjected to the treatment with the aqueous solution, as well as embodiments in which additional regions and embodiments in which the whole surface are/is subjected to this treatment.
- embodiments in which the outer surface of the abutment basic body on which the nanostructures are formed is smooth, preferably machined or polished.
- alternative embodiments can be preferred, in which the outer surface of the abutment basic body on which the nanostructures are formed is rough. This is due to the finding that nanostructure formation has been shown to be favoured on a roughened surface.
- Titanium samples were grinded and polished and were then washed with NaOH at 40% (w/v) and HNO 3 at 40% (w/v) in an ultrasonic bath to remove contaminants, then washed with deionized water to reach a neutral pH and stored at room temperature in 70 vol.-% ethanol.
- samples were treated (“pickled”) for one minute in a solution containing 15 wt.-% HNO 3 and 5 wt.-% HF (solution C1) at room temperature (samples p1).
- solutions C1 diluted twice with deionized water (samples p2), diluted five times with deionized water (samples p5) and diluted ten times with deionized water (samples p10).
- the samples were washed by dipping in a beaker containing deionized water for 10 seconds, then mounted on a sample holder forming a cathode for cathodic polarization (or cathodic hydridation).
- FE-SEM Field Emission Scanning Electron Microscope
- nanostructures in the particular case nano-nodules, with a diameter well below 200 nm were detected as white “spots”. These nanostructures form retention sites for improved protein adherence of the surrounding soft tissue.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Metallurgy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Materials Engineering (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dentistry (AREA)
- General Chemical & Material Sciences (AREA)
- Mechanical Engineering (AREA)
- Electrochemistry (AREA)
- Ceramic Engineering (AREA)
- Medicinal Chemistry (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Dental Prosthetics (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
- The present invention relates to an abutment of a dental implant system for connecting a dental implant and a suprastructure as well as to a process for providing sites of improved protein adherence on an abutment basic body.
- Dental implants are well known in the art. Generally, they comprise an anchoring part intended to be anchored in a patient's jaw bone and a head part intended to form the basis on which a suprastructure, such as a bridge or crown, is mounted. The mounting of the suprastructure is thereby often performed by using an intermediate, i.e. a so-called “abutment” (also referred to as “secondary part”), as it is the case in a “two-part implant system” or “multi-part implant system”.
- Apart from being biocompatible and having sufficient mechanical strength, it is required that the implant provides good osteointegration.
- The term “osteointegration” designates the direct structural and functional connection between living bone and the surface of the implant. A good osteointegration means that the implant, after reaching a primary stability by screwing it into the bone, safely ossifies within a short healing time so that a permanent bond between implant and bone is obtained.
- In the past, much effort has been made in order to improve the osteointegrative properties of implants.
- Besides the importance of the implant's osteointegrative properties, there is on-growing evidence that also a good interaction between the implant system and the surrounding supracrestal connective tissue (in the following referred to as the “soft tissue”) is crucial for a successful implantation. This is supported by the view that the soft tissue plays a fundamental role in establishing an effective seal between the oral environment and the endosseous part of a dental implant and, thus, also a barrier for bacteria to adhere on the soft tissue contact surface and the bone tissue contact surface of the implant system.
- Indeed, the presence of bacteria on the implant system's surface may lead to an inflammation of the peri-implant mucosa, and, if left untreated, the inflammation spreads apically and results in bone resorption.
- As a consequence of the theory that rough surfaces accumulate and retain more plaque than smooth surfaces (see Oral Implantology, Thieme Verlag, 1996, page 438), nowadays, at least the part of the implant system's surface, which comes into contact with the soft tissue, is typically machined.
- As mentioned above, the soft tissue contact surface of the implant system would ideally not only provide a surface showing a low tendency for bacteria to adhere, but also allow a relatively strong and fast interaction between the soft tissue and the implant to be established (also referred to as “soft tissue integration”), in order to quickly provide an effective seal between the oral environment and the endosseous part.
- This applies not only to the dental implant itself, but also to the abutment of a respective dental implant system.
- Aiming at an improved soft tissue integration of the implant system, EP-A-2161000 suggests an abutment comprising a soft tissue contact surface that is at least partially hydroxylated. In this context, improved soft tissue integration is explained by the loose connective tissue to become organized and replaced be newly formed collagen fibers.
- Irrespective of the beneficial effects achieved by the technology described in EP-A-2161000, there is an on-going need for further, simple solutions for improving soft tissue integration of the abutment, and ultimately the dental implant system.
- The object of the present invention is thus to provide an abutment the outer surface of which establishes a good soft tissue integration, i.e. a relatively strong interaction between abutment and soft tissue in a relatively timely manner, and which at the same time shows a low tendency for bacteria to adhere.
- This problem is solved by the subject matter of claim 1. Preferred embodiments of the invention are subject of the dependent claims.
- According to claim 1, the present invention relates to a abutment comprising an abutment basic body extending from an apical end to a coronal end arranged opposite to the apical end, the abutment comprising a dental implant connecting portion facing the apical end and adapted to fit with a corresponding abutment connecting portion of the dental implant and/or an intermediate part to be directly or indirectly connected with the dental implant.
- The abutment further comprises a support portion facing the coronal end designed such to allow the suprastructure to be mounted directly or indirectly, i.e. using at least one intermediate, as it is the case in multi-part dental implant systems.
- According to the invention, the abutment comprises nanostructures formed on the outer surface of the abutment basic body, said nanostructures extending in at least two dimensions to 200 nm at most.
- Preferably, the nanostructures are formed on the outer surface of a soft tissue contact region of the abutment basic body, said region being arranged between the dental implant connecting portion and the support portion of the abutment basic body. The outer surface of the soft tissue contact region is in the following also referred to as “soft tissue contact surface”.
- The nanostructures form retention sites, allowing for an improved initial adherence of proteins of the cells of the surrounding soft tissue. Without wanting to be bound by the theory, transmembrane proteins, specifically integrins, can directly or indirectly, i.e. by mediation of other proteins, adhere to the nanostructures and, thus, establish an anchorage of the cells to the abutment's soft tissue contact surface. In this complex mechanism, laminins, which is linked with the extracellular domain of the integrins, can also play an important role, as well as plasma proteins, such as albumin, fibrinogen and fibronectin.
- Ultimately, the nanostructures forming retention sites allow for an optimal soft tissue interaction of the abutment and, consequently, an effective seal between the dental implant system's endosseous part and the oral environment to be achieved.
- According to a particularly preferred embodiment, the outer surface of the abutment basic body on which the nanostructures are formed is smooth, e.g. machined or polished.
- In other words, the surface topography is smooth when regarded in macroscopic and microscopic scale, but nevertheless provides a nanoscopic structure due to the presence of the nanostructures. These nanostructures are small enough not to interfere with the low plaque forming tendency of the soft tissue contact surface, but big enough to allow proteins of the surrounding soft tissue cells to adhere. As a result, the soft tissue contact surface's tendency for adherence of bacteria is low, while at the same time protein adherence of the surrounding soft tissue cells can take place.
- Alternatively to the outer surface of the abutment basic body being smooth, it can also be minimally rough, i.e. having a roughness as e.g. obtainable by acid etching.
- The term “dental implant” as used in the context of the present invention relates to the primary part of a dental implant system, i.e. the part that is actually implanted in the bone, whereas the term “abutment” relates to the “secondary part” of the dental implant system. The term “suprastructure” relates to the prosthetic element of the dental restoration, and in particular relates to a crown or bridge.
- In that the outer surface of the abutment basic body on which the nanostructures are formed, in particularly the soft tissue contact surface, is preferably smooth, it is in clear distinction from the bone tissue contact surface of the dental implant, which typically comprises a macroscopic topography, achieved e.g. by sand-blasting and/or machining, as well as a microscopic topography, achieved e.g. by acid etching.
- It is understood that the present invention encompasses abutments in which nanostructures are formed on the soft tissue contact surface only, as well as embodiments in which they are formed on the surface of additional regions than the soft tissue contact region, and embodiments in which they are formed on the whole surface of the abutment basic body.
- According to a further preferred embodiment, the nanostructures are at least predominantly in crystalline phase. More preferably, the nanostructures are in an at least approximately purely crystalline phase.
- The nanostructures can have different shapes including a needle-like shape, a leaf-like shape, a flower-like shape, a sphere-like shape or a nodule-like shape.
- In the context of the present invention, the term “needle-like shape” encompasses any shape having a length to diameter ratio of more than 1:1. Thereby, the diameter is to be understood as the expansion of the nanostructure in a direction perpendicular to the longitudinal direction.
- Preferably, the nanostructures have an average length-to-diameter ratio of more than 1 to 1, more preferably of at least 1.5 to 1, most particularly ranging from 1.5 to 1 to 4 to 1.
- As mentioned, the nanostructures according to the present invention preferably extend in at least two dimensions to 200 nm at most. More specifically, the nanostructures preferably have an average diameter of about 10 nm to 150 nm and an average length of about 5 nm to 500 nm.
- It has further been found that by the presence of nanostructures, a relatively high hydrophilicity of the abutment's surface can be achieved, which can further contribute to a good soft tissue interaction. According to a preferred embodiment, at least a part of the surface of the abutment, thus, has a hydrophilicity defined by a contact angle of less than 90°, more preferably less than 30°, most preferably less than 10°, when contacted with water.
- It is further preferred that the abutment basic body is made of titanium or a titanium alloy. A respective basic body allows nanostructures to be formed on its surface in a relatively simple and reproducible manner, as will be shown below.
- In view of its use in the field of implantology, and in particular oral implantology, any suitable grade of titanium or titanium alloy known to the skilled person can be used, including titanium of grade 2 to grade 4.
- When using a titanium alloy, this is preferably a titanium zirconium (TiZr) alloy, typically comprising Zr in an amount of 13 to 17%. Alternatively, a titanium aluminium vanadium alloy, specifically Ti-6Al-4V (TAV), or a titanium aluminium niobium alloy, specifically Ti-6Al-7Nb (TAN), can be used as a titanium alloy suitable for the purpose of the present invention.
- With regard to the use of titanium or a titanium alloy for the abutment basic body, it is further preferred that the nanostructures comprise titanium hydride and/or titanium oxide.
- In case the nanostructures comprise titanium hydride, they typically comprise TiH2, whereas in case the nanostructures comprise titanium oxide, they typically comprise TiO2.
- According to a further aspect, the present invention also relates to a process for providing sites of improved protein adherence on an abutment basic body, as described above.
- According to this process, the nanostructures are grown on the outer surface of the abutment basic body by treating the outer surface of the abutment basic body with an aqueous solution.
- The feature that the nanostructures are grown means that they are not formed by a mechanical removing process or by subjecting the surface of the body to other mechanical structuring processes. Rather, the formation of the nanostructures occurs gradually in that they “build up” over time by treating the outer surface of the abutment basic body with the aqueous solution.
- The term “aqueous solution” as used in the context of the present invention encompasses both pure water as well as a solution in which the solvent is water.
- A particularly good formation/growing of nanostructures has been observed for embodiments in which the aqueous solution is an acidic solution comprising at least one component selected from the group consisting of hydrogen fluoride, nitric acid, hydrochloric acid, sulphuric acid, tartaric acid, oxalic acid, citric acid and acetic acid, and/or mixtures thereof.
- As mentioned above, the abutment basic body is typically made of titanium or a titanium alloy.
- According to a well-controllable and thus preferred process, the growing of the nanostructures is performed by cathodic polarization (also referred to as “cathodic hydridation”), in which the abutment basic body forms the cathode. A detailed description of this process will be given by way of the examples below.
- In this regard, it is particularly preferred that before performing cathodic polarization, at least a portion of the outer surface of the abutment basic body is pickled with a pickling solution in order to at least partially remove a titanium oxide layer present on the outer surface. A pickling solution comprising at least one component selected from the group consisting of nitric acid, hydrofluoric acid, ammonium fluoride, hydrochloric acid and sulphuric acid, and/or mixtures thereof, particularly a mixture of nitric acid and hydrofluoric acid, is thereby preferably used.
- With regard to the cathodic polarization, this is preferably performed in a buffer having a pH in the range from 0 to 6. The temperature is preferably set in a range from 5 to 95° C., preferably from 10 to 75° C., more preferably from 15 to 50° C., most preferably at about room temperature.
- Additionally or alternatively to the above described process using cathodic polarization, the nanostructures can be grown on the outer surface of the abutment basic body by storing the outer surface of the abutment basic body in the aqueous solution.
- The storing is typically carried out by using a 0.9% NaCl solution, more specifically having a pH of 2 to 7, preferably 3 to 6. Likewise, any other suitable aqueous solution can be used including pure water.
- According to a particularly preferred embodiment, the storing is carried out for at least one month, more preferably at least two months, most preferably at least four months. The storage time depends on the surface topography of the outer surface of the abutment basic body. For a machined surface, the storage times required for the growing of the nanostructures has been found to be longer than for a rough surface. However, also for a machined surface, nanostructures are detected after two months of storing.
- With regard to the storing, it is further preferred that this is performed at an elevated temperature, i.e. a temperature above room temperature, since nanostructure formation has been shown to be particularly pronounced at these temperatures.
- A temperature in a range of about 50° C. to 250° C., more particularly about 100° C. to 180° C., and most preferably about 120° C. to 150° C. has been shown to be particularly preferred, since the storing time required for the growing of nanostructures can be shortened substantially. A storing over months is, thus, not required when performing a (hydro-)thermal treatment at the temperatures specified above.
- It is understood that the process of the present invention encompasses embodiments in which only the soft tissue contact region is subjected to the treatment with the aqueous solution, as well as embodiments in which additional regions and embodiments in which the whole surface are/is subjected to this treatment.
- As mentioned, embodiments in which the outer surface of the abutment basic body on which the nanostructures are formed is smooth, preferably machined or polished. Depending on the actual aim to be achieved, alternative embodiments can be preferred, in which the outer surface of the abutment basic body on which the nanostructures are formed is rough. This is due to the finding that nanostructure formation has been shown to be favoured on a roughened surface.
- The present invention is further exemplified by way of the following examples:
- Titanium samples were grinded and polished and were then washed with NaOH at 40% (w/v) and HNO3 at 40% (w/v) in an ultrasonic bath to remove contaminants, then washed with deionized water to reach a neutral pH and stored at room temperature in 70 vol.-% ethanol.
- After the polishing and cleaning steps, some of the samples were treated (“pickled”) for one minute in a solution containing 15 wt.-% HNO3 and 5 wt.-% HF (solution C1) at room temperature (samples p1). Alternatively, samples were treated in a solution C1 diluted twice with deionized water (samples p2), diluted five times with deionized water (samples p5) and diluted ten times with deionized water (samples p10).
- Immediately after the pickling treatment, the samples were washed by dipping in a beaker containing deionized water for 10 seconds, then mounted on a sample holder forming a cathode for cathodic polarization (or cathodic hydridation).
- For the cathodic hydridation, current densities at 5, 10 and 15 mA/cm2 were used. The hydration was performed at room temperature and the duration of the hydridation was set to 0.5, 2 and 5 hours. As electrolyte, tartaric acid at 1 M of concentration, pH 1.9, was used.
- Following the hydridation step, a nanoscale analysis of each of the modified surfaces was performed using a Field Emission Scanning Electron Microscope (FE-SEM; Quanta 200F, FEI, The Netherlands).
- Thereby, nanostructures, in the particular case nano-nodules, with a diameter well below 200 nm were detected as white “spots”. These nanostructures form retention sites for improved protein adherence of the surrounding soft tissue.
Claims (21)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13002955 | 2013-06-07 | ||
EP13002955.6 | 2013-06-07 | ||
PCT/EP2014/001549 WO2014195027A2 (en) | 2013-06-07 | 2014-06-06 | Abutment |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2014/001549 A-371-Of-International WO2014195027A2 (en) | 2013-06-07 | 2014-06-06 | Abutment |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/348,472 Continuation US20210307880A1 (en) | 2013-06-07 | 2021-06-15 | Abutment |
Publications (1)
Publication Number | Publication Date |
---|---|
US20160120625A1 true US20160120625A1 (en) | 2016-05-05 |
Family
ID=48578765
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/896,569 Abandoned US20160120625A1 (en) | 2013-06-07 | 2014-06-06 | Abutment |
US17/348,472 Pending US20210307880A1 (en) | 2013-06-07 | 2021-06-15 | Abutment |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/348,472 Pending US20210307880A1 (en) | 2013-06-07 | 2021-06-15 | Abutment |
Country Status (4)
Country | Link |
---|---|
US (2) | US20160120625A1 (en) |
EP (1) | EP3003203B1 (en) |
ES (1) | ES2887245T3 (en) |
WO (1) | WO2014195027A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11357600B2 (en) | 2014-12-16 | 2022-06-14 | Nobel Biocare Services Ag | Dental implant |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4389067A1 (en) | 2022-12-21 | 2024-06-26 | Institut Straumann AG | Induced controlled regeneration of soft tissue at placement sites of percutaneous dental devices |
Citations (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020031749A1 (en) * | 2000-09-14 | 2002-03-14 | Morgan Vincent J. | Abutment for dental implant and associated components for use therewith |
US20020182567A1 (en) * | 2001-06-04 | 2002-12-05 | Hurson Steven M. | Natural implant system |
US20030059742A1 (en) * | 2001-09-24 | 2003-03-27 | Webster Thomas J. | Osteointegration device and method |
US20040054422A1 (en) * | 2000-11-20 | 2004-03-18 | Pierre Descouts | Endosseous implant |
US20040152034A1 (en) * | 2003-02-05 | 2004-08-05 | Cummings Kevin M. | Use of ceramics in dental and orthodontic applications |
US20050031663A1 (en) * | 1997-05-16 | 2005-02-10 | Cecilia Larsson | Implant element |
US20060154206A1 (en) * | 2002-07-19 | 2006-07-13 | Ingela Petersson | Implant and a method for treating an implant surface |
US20070110890A1 (en) * | 2005-11-14 | 2007-05-17 | Berckmans Bruce Iii | Deposition of discrete nanoparticles on an implant surface |
US20070275350A1 (en) * | 2003-12-11 | 2007-11-29 | Jan Hall | Arrangement of an Implant and/or a Unit Belonging to Said Implant, and Method for Production of the Implant and/or Unit |
US20080044795A1 (en) * | 2003-12-11 | 2008-02-21 | Jan Hall | Implant |
US20080220394A1 (en) * | 2006-10-24 | 2008-09-11 | Biomet 3I, Inc. | Deposition of discrete nanoparticles on a nanostructured surface of an implant |
US20080261178A1 (en) * | 2007-04-19 | 2008-10-23 | Straumann Holding Ag | Process for providing a topography to the surface of a dental implant |
US20090035722A1 (en) * | 2007-08-01 | 2009-02-05 | Ganesan Balasundaram | Hydroxyapatite coated nanostructured titanium surfaces |
US20090164027A1 (en) * | 2006-01-31 | 2009-06-25 | Holger Zipprich | Process for producing a metal body and metal bodies |
US20090191507A1 (en) * | 2008-01-28 | 2009-07-30 | Biomet 3I, Llc | Implant surface with increased hydrophilicity |
US20090220561A1 (en) * | 2005-04-28 | 2009-09-03 | Sungho Jin | Compositions comprising nanostructures for cell, tissue and artificial organ growth, and methods for making and using same |
US7655586B1 (en) * | 2003-05-29 | 2010-02-02 | Pentron Ceramics, Inc. | Dental restorations using nanocrystalline materials and methods of manufacture |
US20100173264A1 (en) * | 2007-07-09 | 2010-07-08 | Astra Tech Ab | Nanosurface |
US20100255447A1 (en) * | 2009-04-07 | 2010-10-07 | University Of Arkansas | Advanced bio-compatible polymer surface coatings for implants and tissue engineering scaffolds |
US20100303722A1 (en) * | 2006-06-23 | 2010-12-02 | Sungho Jin | Articles comprising large-surface-area bio-compatible materials and methods for making and using them |
US20110033661A1 (en) * | 2005-03-21 | 2011-02-10 | The Regents Of The University Of California | Controllable nanostructuring on micro-structured surfaces |
EP2314251A1 (en) * | 2009-10-20 | 2011-04-27 | Giuseppe Vrespa | Dental implant with nanotube surface with micrometric cavities |
US20110125263A1 (en) * | 2007-08-24 | 2011-05-26 | Brown University | Method for producing nanostructures on a surface of a medical implant |
US20110151026A1 (en) * | 2007-07-09 | 2011-06-23 | Astra Tech Ab | Bone tissue implant comprising lithium ions |
US20110171600A1 (en) * | 2010-01-14 | 2011-07-14 | National Taipei University Of Technology | Bio-Implant Having a Screw Body with Nanoporous Spiral Groove and the Method of Making the Same |
US20110233169A1 (en) * | 2010-03-29 | 2011-09-29 | Biomet 3I, Llc | Titanium nano-scale etching on an implant surface |
US20110306016A1 (en) * | 2010-06-10 | 2011-12-15 | Astra Tech Ab | Dental fixture |
US20120010599A1 (en) * | 2010-07-06 | 2012-01-12 | The Regents Of The University Of California | Inorganically surface-modified polymers and methods for making and using them |
US20120288699A1 (en) * | 2011-05-11 | 2012-11-15 | Ahlberg Elisabet | Biocompatible component |
US20130045360A1 (en) * | 2010-01-29 | 2013-02-21 | Georgia Tech Research Corporation | Surface modification of implant devices |
WO2013056844A1 (en) * | 2011-10-21 | 2013-04-25 | Straumann Holding Ag | Process for providing structures for improved protein adherence on the surface of a body |
US20130189646A1 (en) * | 2012-01-23 | 2013-07-25 | Mark N. Hochman | Method and apparatus for recording spatial gingival soft tissue relationship to implant placement within alveolar bone for immediate-implant placement |
US8512741B2 (en) * | 2006-09-01 | 2013-08-20 | Cornell Research Foundations, Inc. | Electrospun calcium phosphate nanofibers |
WO2013180889A2 (en) * | 2012-05-29 | 2013-12-05 | Biomet 3I, Llc | Dental implant system having enhanced soft-tissue growth features |
US20140186799A1 (en) * | 2012-12-27 | 2014-07-03 | Metal Industries Research & Development Centre | Dental implant |
US9108295B2 (en) * | 2011-12-22 | 2015-08-18 | Dentsply International Inc. | Blasting metallic implants with titanium oxide |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH1143799A (en) * | 1997-07-24 | 1999-02-16 | Nikon Corp | Preparation of titanium oxide film having bio-affinity |
ATE518494T1 (en) * | 2006-02-28 | 2011-08-15 | Straumann Holding Ag | CONSTRUCTION WITH HYDROXYLATED SURFACE |
WO2014195025A2 (en) * | 2013-06-07 | 2014-12-11 | Straumann Holding Ag | Dental implant |
GB2523814A (en) * | 2014-03-07 | 2015-09-09 | Nobel Biocare Services Ag | Implant surface composition |
-
2014
- 2014-06-06 WO PCT/EP2014/001549 patent/WO2014195027A2/en active Application Filing
- 2014-06-06 US US14/896,569 patent/US20160120625A1/en not_active Abandoned
- 2014-06-06 ES ES14729219T patent/ES2887245T3/en active Active
- 2014-06-06 EP EP14729219.7A patent/EP3003203B1/en active Active
-
2021
- 2021-06-15 US US17/348,472 patent/US20210307880A1/en active Pending
Patent Citations (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050031663A1 (en) * | 1997-05-16 | 2005-02-10 | Cecilia Larsson | Implant element |
US20020031749A1 (en) * | 2000-09-14 | 2002-03-14 | Morgan Vincent J. | Abutment for dental implant and associated components for use therewith |
US20040054422A1 (en) * | 2000-11-20 | 2004-03-18 | Pierre Descouts | Endosseous implant |
US20020182567A1 (en) * | 2001-06-04 | 2002-12-05 | Hurson Steven M. | Natural implant system |
US20030059742A1 (en) * | 2001-09-24 | 2003-03-27 | Webster Thomas J. | Osteointegration device and method |
US20060154206A1 (en) * | 2002-07-19 | 2006-07-13 | Ingela Petersson | Implant and a method for treating an implant surface |
US20040152034A1 (en) * | 2003-02-05 | 2004-08-05 | Cummings Kevin M. | Use of ceramics in dental and orthodontic applications |
US7655586B1 (en) * | 2003-05-29 | 2010-02-02 | Pentron Ceramics, Inc. | Dental restorations using nanocrystalline materials and methods of manufacture |
US20070275350A1 (en) * | 2003-12-11 | 2007-11-29 | Jan Hall | Arrangement of an Implant and/or a Unit Belonging to Said Implant, and Method for Production of the Implant and/or Unit |
US20080044795A1 (en) * | 2003-12-11 | 2008-02-21 | Jan Hall | Implant |
US9931184B2 (en) * | 2003-12-11 | 2018-04-03 | Nobel Biocare Services Ag | Arrangement with an implant and/or a unit belonging to said implant, and method for production of the implant and/or unit |
US20110033661A1 (en) * | 2005-03-21 | 2011-02-10 | The Regents Of The University Of California | Controllable nanostructuring on micro-structured surfaces |
US20090220561A1 (en) * | 2005-04-28 | 2009-09-03 | Sungho Jin | Compositions comprising nanostructures for cell, tissue and artificial organ growth, and methods for making and using same |
US20070110890A1 (en) * | 2005-11-14 | 2007-05-17 | Berckmans Bruce Iii | Deposition of discrete nanoparticles on an implant surface |
US20090164027A1 (en) * | 2006-01-31 | 2009-06-25 | Holger Zipprich | Process for producing a metal body and metal bodies |
US20100303722A1 (en) * | 2006-06-23 | 2010-12-02 | Sungho Jin | Articles comprising large-surface-area bio-compatible materials and methods for making and using them |
US8512741B2 (en) * | 2006-09-01 | 2013-08-20 | Cornell Research Foundations, Inc. | Electrospun calcium phosphate nanofibers |
US20080220394A1 (en) * | 2006-10-24 | 2008-09-11 | Biomet 3I, Inc. | Deposition of discrete nanoparticles on a nanostructured surface of an implant |
US7972648B2 (en) * | 2006-10-24 | 2011-07-05 | Biomet 3I, Llc | Deposition of discrete nanoparticles on a nanostructured surface of an implant |
US20080261178A1 (en) * | 2007-04-19 | 2008-10-23 | Straumann Holding Ag | Process for providing a topography to the surface of a dental implant |
US20110151026A1 (en) * | 2007-07-09 | 2011-06-23 | Astra Tech Ab | Bone tissue implant comprising lithium ions |
US20100173264A1 (en) * | 2007-07-09 | 2010-07-08 | Astra Tech Ab | Nanosurface |
US20090035722A1 (en) * | 2007-08-01 | 2009-02-05 | Ganesan Balasundaram | Hydroxyapatite coated nanostructured titanium surfaces |
US20110125263A1 (en) * | 2007-08-24 | 2011-05-26 | Brown University | Method for producing nanostructures on a surface of a medical implant |
US20090191507A1 (en) * | 2008-01-28 | 2009-07-30 | Biomet 3I, Llc | Implant surface with increased hydrophilicity |
US20100255447A1 (en) * | 2009-04-07 | 2010-10-07 | University Of Arkansas | Advanced bio-compatible polymer surface coatings for implants and tissue engineering scaffolds |
EP2314251A1 (en) * | 2009-10-20 | 2011-04-27 | Giuseppe Vrespa | Dental implant with nanotube surface with micrometric cavities |
US20110171600A1 (en) * | 2010-01-14 | 2011-07-14 | National Taipei University Of Technology | Bio-Implant Having a Screw Body with Nanoporous Spiral Groove and the Method of Making the Same |
US20130045360A1 (en) * | 2010-01-29 | 2013-02-21 | Georgia Tech Research Corporation | Surface modification of implant devices |
US20110233169A1 (en) * | 2010-03-29 | 2011-09-29 | Biomet 3I, Llc | Titanium nano-scale etching on an implant surface |
US20110306016A1 (en) * | 2010-06-10 | 2011-12-15 | Astra Tech Ab | Dental fixture |
US20120010599A1 (en) * | 2010-07-06 | 2012-01-12 | The Regents Of The University Of California | Inorganically surface-modified polymers and methods for making and using them |
US20120288699A1 (en) * | 2011-05-11 | 2012-11-15 | Ahlberg Elisabet | Biocompatible component |
WO2013056844A1 (en) * | 2011-10-21 | 2013-04-25 | Straumann Holding Ag | Process for providing structures for improved protein adherence on the surface of a body |
US20140342316A1 (en) * | 2011-10-21 | 2014-11-20 | Straumann Holding Ag | Process for providing structures for improved protein adherence on the surface of a body |
US9108295B2 (en) * | 2011-12-22 | 2015-08-18 | Dentsply International Inc. | Blasting metallic implants with titanium oxide |
US20130189646A1 (en) * | 2012-01-23 | 2013-07-25 | Mark N. Hochman | Method and apparatus for recording spatial gingival soft tissue relationship to implant placement within alveolar bone for immediate-implant placement |
WO2013180889A2 (en) * | 2012-05-29 | 2013-12-05 | Biomet 3I, Llc | Dental implant system having enhanced soft-tissue growth features |
US20130323678A1 (en) * | 2012-05-29 | 2013-12-05 | Biomet 3I, Llc | Dental implant system having enhanced soft-tissue growth features |
US20140186799A1 (en) * | 2012-12-27 | 2014-07-03 | Metal Industries Research & Development Centre | Dental implant |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11357600B2 (en) | 2014-12-16 | 2022-06-14 | Nobel Biocare Services Ag | Dental implant |
US11918434B2 (en) | 2014-12-16 | 2024-03-05 | Nobel Biocare Services Ag | Dental implant |
Also Published As
Publication number | Publication date |
---|---|
WO2014195027A3 (en) | 2015-04-09 |
WO2014195027A2 (en) | 2014-12-11 |
EP3003203A2 (en) | 2016-04-13 |
EP3003203B1 (en) | 2021-07-28 |
US20210307880A1 (en) | 2021-10-07 |
ES2887245T3 (en) | 2021-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9642680B2 (en) | Dental implant | |
US10765494B2 (en) | Titanium nano-scale etching on an implant surface | |
US11331167B2 (en) | Implant system with hydroxylated soft tissue contact surface | |
US11786342B2 (en) | Surface area of a ceramic body and ceramic body | |
CN100396255C (en) | An implant and a method for treating an implant surface | |
EP2828100B1 (en) | Surface treatment for an implant surface | |
US20210307880A1 (en) | Abutment | |
US20070202464A1 (en) | One-Part Implant with a Hydroxylated Soft Tissue Contact Surface | |
NO321694B1 (en) | Sterile implant with a surface modified for improved biocompatibility, as well as methods for making the same. | |
US10426577B2 (en) | Surface treatment for an implant surface | |
TW200922529A (en) | Artificial implant with voids on surface thereof and method for producing the same | |
CZ2017809A3 (en) | Two-piece dental intra-implant and how to prepare it |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: STRAUMANN HOLDING AG, SWITZERLAND Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BERNER, SIMON;REEL/FRAME:037407/0747 Effective date: 20151210 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |